Most Recent
Spanish construction company Técnicas Reunidas can't block two Pinsent Masons solicitors, formerly with Norton Rose, from representing Downer EDI Engineering in an ICC arbitration between the two companies, with an appeals court saying unanswered emails provided sufficient proof a retainer had been terminated.
A judge on Friday bemoaned the slow progress of an unfair dismissal suit brought against the CFMMEU by two whistleblowers, telling lawyers at a hearing Friday he wanted "something to happen" in the case
A judge has thrown out the truth defence claimed by the ABC and Fairfax Media in a case brought by Chinese billionaire and philanthropist Dr Chau Chak Wing.
Telecommunications giant Optus has won court approval to access employee documents in order to pinpoint the location of a suspected fraudster who obtained over 3,400 Optus mobile devices.
Auditing firm Deloitte Touche Tohmatsu wants to challenge a ruling that forces some of its partners to hand over evidence to shareholders in a class action over accounting work for collapsed engineering company Hastie Group.
The decision by a federal judge to refuse calls for a confidentiality order keeping under wraps S&P Global's massive class action settlement is a welcome one, experts say, and a preview of judgments to come.
Bannister Law is investigating a possible class action against providers of direct life insurance, in the wake of an ASIC report that found many insurers used aggressive sales tactics and didn't provide consumers with enough information about the products they sold.
Chinese tech company Hytera Communications Corporation has been ordered to hand over source code for all radio devices at the heart of a international patent dispute with Motorola Solutions.
A judge on Thursday struck out former Prime Minister Mark Latham's defence in a defamation case filed against him by the political editor of pop culture site Junkee, calling it an "extraordinary document" and the "antithesis of a pleading".
Generic drug maker Alphapharm is fighting a bid by global pharmaceutical giant Sanofi-Aventis to block the listing of one of its injector pens, saying the proposed injunction should be denied because Sanofi is seeking to amend the patent at issue.